Hoth Therapeutics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Hoth Therapeutics.
Hoth Therapeutics Overview
About Hoth Therapeutics
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer’s or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
Founded
2017
HQ
Employees
6
Website
Financials (FY)
EV
$20M
Valuation Multiples
Start free trial
Hoth Therapeutics Financials
Hoth Therapeutics reported last fiscal year revenue of -.
In the same fiscal year, Hoth Therapeutics generated had net loss of ($18M).
Hoth Therapeutics P&L
In the most recent fiscal year, Hoth Therapeutics reported revenue of - and net income of ($18M).
Hoth Therapeutics is unprofitable as of last fiscal year, with net margin of -.
Financial data powered by Morningstar, Inc.
Hoth Therapeutics Stock Performance
Hoth Therapeutics has current market cap of $26M, and enterprise value of $20M.
Hoth Therapeutics' stock price is $1.37.
Hoth Therapeutics has an EPS (earnings per share) of $-0.94.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20M | $26M | 0.0% | - | - | - | $-0.94 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHoth Therapeutics Valuation Multiples
Hoth Therapeutics Financial Valuation Multiples
As of August 14, 2026, Hoth Therapeutics has market cap of $26M and EV of $20M.
Hoth Therapeutics has a P/E ratio of (1.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hoth Therapeutics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Hoth Therapeutics Margins & Growth Rates
Hoth Therapeutics grew net profit by 20% in the last fiscal year.
Hoth Therapeutics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hoth Therapeutics Operational KPIs
Hoth Therapeutics' revenue per employee in the last FY averaged $0.0M.
Data powered by FactSet, Inc. and Morningstar, Inc.
Hoth Therapeutics Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Hoth Therapeutics competitors and their valuation data. Start Free Trial | ||||||
Hoth Therapeutics VC Funding History
Before going public, Hoth Therapeutics raised $4M in total equity funding, across 2 rounds.
Hoth Therapeutics Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hoth Therapeutics
| When was Hoth Therapeutics founded? | Hoth Therapeutics was founded in 2017. |
| Where is Hoth Therapeutics headquartered? | Hoth Therapeutics is headquartered in United States. |
| How many employees does Hoth Therapeutics have? | As of today, Hoth Therapeutics has over 6 employees. |
| Is Hoth Therapeutics publicly listed? | Yes, Hoth Therapeutics is a public company listed on Nasdaq. |
| What is the stock symbol of Hoth Therapeutics? | Hoth Therapeutics trades under HOTH ticker. |
| When did Hoth Therapeutics go public? | Hoth Therapeutics went public in 2019. |
| Who are competitors of Hoth Therapeutics? | Hoth Therapeutics main competitors include |
| What is the current market cap of Hoth Therapeutics? | Hoth Therapeutics' current market cap is $26M. |
| Is Hoth Therapeutics profitable? | No, Hoth Therapeutics is not profitable. |
| How many companies Hoth Therapeutics has acquired to date? | Hoth Therapeutics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Hoth Therapeutics has invested to date? | Hoth Therapeutics hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Hoth Therapeutics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.